Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Review in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 2 institutions in 1 country.
Piotr DomańskiDepartment of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.ORCID 0009-0003-2205-4093
Mateusz PiętakDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.ORCID 0000-0001-6451-1238
Szymon StanetaDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Weronika FortuniakDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Barbara KruczykDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.ORCID 0009-0001-5782-7151
Adam KobiernikDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.ORCID 0009-0003-4879-6837
Piotr BakułaDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Anna MydlakDepartment of Head and Neck Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Tomasz DemkowDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Bożena Sikora-KupisDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.
Paulina DumnickaChair of Biochemistry, Jagiellonian University Medical College, 31-034 Kraków, Poland.ORCID 0000-0003-3667-857X
Jakub KucharzDepartment of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5, 02-781 Warsaw, Poland.ORCID 0000-0001-5388-8910
The Maria Sklodowska-Curie National Research Institute of Oncology · PLJagiellonian University · PL
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review. · full record | OpenQuestion